FMCFMC CORP
Chemicals & Allied Products
- Revenue
- $3.5B
- 18% YoY
- Operating margin
- -47.0%
- 494% YoY
- EBITDA
- −$1.5B
- 313% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $3.4B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear-47× cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $5.0B | $5.8B | $4.5B | $4.2B | $3.5B | 18% |
| Operating income | $1.0B | $1.1B | $556M | $507M | −$1.6B | 421% |
| Net income | $740M | $737M | $1.3B | $341M | −$2.2B | 756% |
| Operating cash flow | $899M | $660M | −$300M | $737M | −$6M | 101% |
| Capex | $100M | $142M | $134M | $68M | $96M | 42% |
| Stock-based comp | $18M | $24M | $26M | $24M | $24M | 0.8% |
| Buybacks | $400M | $100M | $75M | $0 | $0 | |
| Dividends | $247M | $268M | $291M | $291M | $291M | 0.2% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $16K · 1
- Net
- −$16K
Pay vs performance
No pay-versus-performance disclosure yet.